241 related articles for article (PubMed ID: 23523318)
21. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.
Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH
Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951
[TBL] [Abstract][Full Text] [Related]
23. DNA hydroxymethylation of colorectal primary carcinoma and its association with survival.
Zhong A; Tian Y; Zhang H; Lai M
J Surg Oncol; 2018 Apr; 117(5):1029-1037. PubMed ID: 29529342
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?
Dubois S; Mareschal S; Picquenot JM; Viailly PJ; Bohers E; Cornic M; Bertrand P; Veresezan EL; Ruminy P; Maingonnat C; Marchand V; Lanic H; Penther D; Bastard C; Tilly H; Jardin F
Oncotarget; 2015 Jun; 6(18):16712-24. PubMed ID: 25762637
[TBL] [Abstract][Full Text] [Related]
25. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.
Scartozzi M; Bearzi I; Mandolesi A; Galizia E; Pierantoni C; Loupakis F; Berardi R; Zaniboni A; Quadri A; Zorzi F; Biagetti S; Loretelli C; Biscotti T; Labianca R; Masi G; Falcone A; Cascinu S
Anal Quant Cytol Histol; 2009 Dec; 31(6):417-23. PubMed ID: 20698358
[TBL] [Abstract][Full Text] [Related]
27. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
28. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
Behrens C; Solis LM; Lin H; Yuan P; Tang X; Kadara H; Riquelme E; Galindo H; Moran CA; Kalhor N; Swisher SG; Simon GR; Stewart DJ; Lee JJ; Wistuba II
Clin Cancer Res; 2013 Dec; 19(23):6556-65. PubMed ID: 24097870
[TBL] [Abstract][Full Text] [Related]
29. Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer.
Liu YL; Gao X; Jiang Y; Zhang G; Sun ZC; Cui BB; Yang YM
J Cancer Res Clin Oncol; 2015 Apr; 141(4):661-9. PubMed ID: 25326896
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer.
Lin Q; Wei Y; Zhong Y; Zhu D; Ren L; Xu P; Zheng P; Feng Q; Ji M; Lv M; Liang C; Xu J
Tumour Biol; 2014 Oct; 35(10):9743-50. PubMed ID: 24972972
[TBL] [Abstract][Full Text] [Related]
31. Enhancer of zeste homolog 2 expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma: a comparative study and review of the literature.
Xu B; Abourbih S; Sircar K; Kassouf W; Mansure JJ; Aprikian A; Tanguay S; Brimo F
Arch Pathol Lab Med; 2013 Oct; 137(10):1326-36. PubMed ID: 24079759
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of β1 integrin expression in colorectal liver metastases.
Vassos N; Rau T; Merkel S; Feiersinger F; Geppert CI; Stürzl M; Hohenberger W; Croner RS
Int J Clin Exp Pathol; 2014; 7(1):288-300. PubMed ID: 24427350
[TBL] [Abstract][Full Text] [Related]
33. The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma.
Gao SB; Xu B; Ding LH; Zheng QL; Zhang L; Zheng QF; Li SH; Feng ZJ; Wei J; Yin ZY; Hua X; Jin GH
J Hepatol; 2014 Oct; 61(4):832-9. PubMed ID: 24845612
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS
J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284
[TBL] [Abstract][Full Text] [Related]
35. High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas.
Qian Y; Li Y; Zheng C; Lu T; Sun R; Mao Y; Yu S; Fan H; Zhang Z
Cancer Genet; 2020 Jul; 245():17-26. PubMed ID: 32534446
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases.
Chen J; Li Q; Wang C; Wu J; Zhao G
Ann Surg Oncol; 2010 Jun; 17(6):1555-63. PubMed ID: 20069460
[TBL] [Abstract][Full Text] [Related]
37. Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma.
Lien HC; Jeng YM; Jhuang YL; Yuan RH
PLoS One; 2018; 13(10):e0206261. PubMed ID: 30356299
[TBL] [Abstract][Full Text] [Related]
38. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
[TBL] [Abstract][Full Text] [Related]
39. Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer.
Fornaro L; Faviana P; De Gregorio V; Vivaldi C; Paolicchi E; Masi G; Loupakis F; Sensi E; Lupi C; Fontanini G; Wang Y; Danesi R; Falcone A; Crea F
BMC Cancer; 2015 Nov; 15():874. PubMed ID: 26553291
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of methylation of CpG island in cystathionine beta synthase promoter and clinicopathological features in colorectal cancer].
Tu XH; Huang SX; Li WS; Song JX
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):351-5. PubMed ID: 24054011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]